Effect of Depressin Screening and Care Program at Community Health Center

Depression Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01626703
• Other study ID #: A102065_2012_2
• Status: Completed
• Phase: N/A
• First received: June 20, 2012
• Last updated: March 9, 2016
• Start date: June 2012
• Est. completion date: March 2013

Study information

• Verified date: March 2016
• Source: National Clinical Research Coordination Center, Seoul, Korea
• Contact: n/a
• Is FDA regulated: No
• Health authority: Korea: Ministry of Health and Welfare
• Study type: Interventional

Clinical Trial Summary

Depression affect between 5% and 10% of older adults seen in the primary care setting.Late-life depression is often chronic or recurrent and is associated with substantial suffering, functional impairment, and diminished health-related quality of life.Depressed, older primary care patients are frequent users of general medical services and may have poor adherence to medical treatments.They are also at increased risk of death from suicide and medical illnesses. The aim of this study is to examine whether depression screening and health care practitioner feedback are increased depression treatment rate.

Depression screening is provided 60 or more who visited community health care center with a 15-item Geriatric Depression Scale.GDS scores of 10 or more were classified depression positive. Intervention group participants received twice remind calls from primary care nurse.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 86
• Est. completion date: March 2013
• Est. primary completion date: December 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 60 Years and older

Eligibility

Inclusion Criteria:

• 60 or more

• 10 or more in GDS scor

Exclusion Criteria:

• severe cognitive problem

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Screening

Related Conditions & MeSH terms

• Depression
• Elderly
• Screening

Intervention

Other:
• Reminding call

Locations

Country	Name	City	State
Korea, Republic of	Chungju community health care center	Chungju	Choongbuk

Sponsors (1)

Lead Sponsor	Collaborator
National Clinical Research Coordination Center, Seoul, Korea

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Reuptake rate		12 weeks	No
Secondary	reduced depressive symptoms	Geriatric Depression Scale Short Form (SGDS)	12 weeks	No
Secondary	changed perceived heath status	Visual Analogue Scale (VAS)	12 weeks	No